undamentalytics Newsletter
Sign in

Biomerica Inc cash flow statement

In fiscal 2026, Biomerica Inc's operations generated −$3.4m of cash; it spent $0 on capital projects, leaving free cash flow of −$3.4m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011May 20112012May 20122013May 20132014May 20142015May 20152016May 20162017May 20172018May 20182019May 20192020May 20202021May 20212022May 20222023May 20232024May 20242025May 20252026May 2026LTMAug 2026
Cash from operations001−1−0−0−1−1−2−4−5−0−5−5−4−3−4
Depreciation and amortisation00000000000000000
Stock-based pay———————00—1111000
Capital spending00000000000000000
Free cash flow0−01−1−0−0−1−1−2−4−5−1−6−5−4−3−4
Free cash flow after stock pay———————−1−2—−7−2−7−6−4−4−4
Shares issued——00—1—12101210—223

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: BMRA vs INBSBMRA vs CNSYBMRA vs MCTA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Biomerica Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biomerica Inc.